by Aline Fieck | Dec 10, 2025 | Featured, News, Updates
PARIS, FRANCE, December 10, 2025 – Qynapse is participating in the 17th French Congress of Psychiatry, taking place from December 10 to 13 in Cannes Our team is on site to engage with clinicians, researchers, and mental health professionals, and to highlight how...
by Aline Fieck | Dec 10, 2025 | Featured, News, Updates
PARIS, FRANCE, December 10, 2025 – Qynapse is present at the USPALZ 2025 Congress Qynapse is participating in the USPALZ 2025 Congress to present its solutions dedicated to neurodegenerative diseases. This presence reflects Qynapse’s mission to advance diagnostic...
by Aline Fieck | Dec 1, 2025 | Featured, News, Updates
PARIS, FRANCE, December 1, 2025 – Qynapse is present at CTAD Clinical Trials on Alzheimer’s Disease 2025 in San Diego. Meet Olivier Courrèges and Michael Tunkelrott and discover how Qynapse’s clinically validated AI solutions are advancing Alzheimer’s disease...
by Aline Fieck | Jul 27, 2025 | Featured, News
Toronto, Canada – July 28, 2025 – Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for neurological diseases, including Alzheimer’s disease (AD), presented new data at the Alzheimer’s...
by Aline Fieck | May 6, 2025 | Featured, News, Updates
PARIS, FRANCE, May 6, 2025 – We are thrilled to share that Qynapse’s collaborative study with Amsterdam UMC has been published in Alzheimer’s Research & Therapy: “Clinical phenotypes of Alzheimer’s disease: investigating atrophy patterns and their pathological...
by Aline Fieck | Apr 5, 2025 | Featured, News
PARIS, FRANCE, April 5, 2025 –Dr. Luca Villa, Senior Clinical Scientist, presented our work focused on using QyScore® and QyPredict® to differentiate patients with progressive supranuclear palsy from patients with Parkinson’s disease. The presentation, titled...
